# T2 FSL2 Weight Loss

> **NCT05168306** · — · TERMINATED · sponsor: **Abbott Diabetes Care** · enrollment: 43 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DEVICE:** FreeStyle Libre 2 Flash Glucose Monitoring System

## Key facts

- **NCT ID:** NCT05168306
- **Lead sponsor:** Abbott Diabetes Care
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2021-12-05
- **Primary completion:** 2023-01-30
- **Final completion:** 2023-07-19
- **Target enrollment:** 43 (ACTUAL)
- **Why stopped:** Slow enrollment and Study no longer required
- **Last updated:** 2025-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05168306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05168306, "T2 FSL2 Weight Loss". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05168306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*